인슐린 펌프 시장 : 산업 동향과 세계 예측(-2035년) - 펌프 유형별, 자동화 정도별, 배터리 유형별, 대상 당뇨병 유형별, 유통 채널별, 지역별

Insulin Pump Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Pump, Degree of Automation, Type of Battery, Type of Diabetes Targeted, Distribution Channel and Key Geography

US $ 4,799 ￦ 6,696,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,766,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,789,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,115,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

인슐린 펌프 시장 규모는 2024년에는 58억 달러에 달할 것으로 예상되며, 2035년까지의 예측 기간 중 8%의 CAGR로 확대할 것으로 예측됩니다.

세계보건기구(WHO)에 따르면 현재 전 세계에서 4억 2,000만 명 이상이 당뇨병을 앓고 있습니다. 당뇨병은 실명, 심장마비, 신부전, 하지 절단, 뇌졸중 등 심각한 건강 문제의 주요 원인으로 부상하고 있습니다. 당뇨병의 전통적인 치료법으로는 경구약, 인슐린 주사, 생활습관 개선 등이 있습니다. 그러나 매일 여러 번 주사를 맞아야 하는 기존의 당뇨병 관리 방법은 불편함과 불편함을 동반하는 경우가 많으며, 환자들의 결과도 좋지 않습니다. 이러한 이유로, 부정확한 투약량, 주사침 손상 위험, 주사 부위에 따른 인슐린 흡수율의 편차 등 약물전달과 관련된 몇 가지 우려사항이 제기되고 있습니다.

당뇨병 약물전달 장비와 관련된 한계를 고려할 때 인슐린 펌프는 인슐린 투여를 위한 선호되는 선택이 되고 있습니다. 이 작고 가벼운 장비는 환자의 필요에 따라 인슐린을 지속적으로 또는 간헐적으로 주입하도록 설계되어 당뇨병 관리에 정확하고 적응력있는 접근 방식을 제공합니다. 주목할 만한 점은 대부분의 인슐린 펌프는 벨트에 장착할 수 있으며, 펌프와 피하 지방 조직에 설치된 주입 세트를 연결하는 튜브로 구성되어 있다는 점입니다. 일부 인슐린 펌프는 패치로 피부에 직접 부착 할 수 있으며 환자는 자유롭게 움직일 수 있습니다. 이 장비는 정확하고 조절 가능한 인슐린 투여, 맞춤형 기초 용량, 식사 중 볼러스 투여, 편안함 향상, 저혈당 및 고혈당 위험 감소 등 많은 이점을 제공하여 삶의 질을 향상시키는 데 기여합니다. 또한 인슐린 펌프는 간단한 투여 과정으로 구성되어 가정내 자가 투약을 개선하고 인슐린 투여에 대한 의료 서비스 프로바이더에 대한 의존도를 줄이는 것으로 입증되었습니다.

세계의 인슐린 펌프 시장에 대해 조사했으며, 시장의 개요와 펌프 유형별, 자동화 정도별, 배터리 유형별, 대상으로 하는 당뇨병 유형별, 유통 채널별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 서문

제2장 조사 방법

제3장 시장 역학

제4장 경제 및 기타 프로젝트 특유 고려 사항

제5장 개요

제6장 서론

• 장의 개요
• 당뇨병의 개요
• 인슐린 펌프
• 향후 전망

제7장 인슐린 펌프 : 시장 구도

• 장의 개요
• 인슐린 펌프 : 시장 구도
• 인슐린 펌프 : 제조업체 리스트

제8장 기업 개요 : 북미에 기반한 인슐린 펌프 제조업체

• 장의 개요
• Beta Bionics
• Insulet
• MannKind
• Medtronic
• Tandem Diabetes Care

제9장 기업 개요 : 유럽에 기반한 인슐린 펌프 제조업체

• 장의 개요
• CeQur
• Roche
• ViCentra
• Ypsomed

제10장 기업 개요 : 아시아태평양에 기반한 인슐린 펌프 제조업체

• 장의 개요
• EOFlow
• Medtrum Technologies
• MicroPort
• Microtech Medical
• SOOIL Development
• Terumo

제11장 특허 분석

제12장 시장 영향 분석

제13장 세계의 인슐린 펌프 시장

제14장 인슐린 펌프 시장(펌프 유형별)

제15장 인슐린 펌프 시장(자동화 정도별)

제16장 인슐린 펌프 시장(배터리 유형별)

제17장 인슐린 펌프 시장(대상 당뇨병 유형별)

제18장 인슐린 펌프 시장(유통 채널별)

제19장 인슐린 펌프 시장(지역별)

제20장 결론

제21장 이그제큐티브 인사이트

제22장 부록 I : 표 형식 데이터

제23장 부록 II : 기업 및 단체 리스트

KSA

영문 목차

영문목차

The Insulin Pump Market is expected to reach USD 5.8 billion in 2024 and is anticipated to grow at a CAGR of 8% during the forecast period till 2035.

According to the World Health Organization, over 420 million people are currently suffering from diabetes worldwide. Diabetes has emerged as a leading cause of serious health issues including blindness, heart attacks, kidney failure, lower limb amputation, and strokes. The traditional treatment options for diabetes include oral medications, insulin injections and lifestyle modifications. However, conventional diabetes management techniques, characterized by multiple daily injections, are often associated with discomfort, inconvenience, and suboptimal patient outcomes. This raises several concerns related to drug delivery, including dosing inaccuracies, the risk of needlestick injuries, and variability in insulin absorption depending on the site of injection.

Given the limitations associated with diabetes drug delivery devices, insulin pumps have become a preferred option for insulin administration. These compact, lightweight devices are designed to deliver continuous or intermittent insulin infusions based on the patient's needs, offering a precise and adaptable approach to diabetes management. Notably, most insulin pumps can be worn on a belt and consist of a tube that connects the pump to an infusion set placed in the subcutaneous fatty tissue. Some insulin pumps can be worn directly on the skin as patches, allowing patients to move freely. These devices offer numerous advantages, including accurate and adjustable insulin delivery, customizable basal rates, bolus dosing during meals, enhanced comfort, and reduced risk of hypoglycemia and hyperglycemia, contributing to the enhanced quality of life. Further, insulin pumps comprise of a simple administration process that has proven to improve self-medication at-home settings, thereby reducing reliance on healthcare providers for insulin administration.

Key Market Segments

Type of Pump

• Tethered Pumps
• Patch Pumps

Degree of Automation

• Manual Pumps
• Automated / Smart Pumps

Type of Battery

• Replaceable Batteries
• Rechargeable Batteries

Type of Diabetes Targeted

• Type 1 Diabetes
• Type 2 Diabetes

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Other Pharmacies

Key Geography

• North America (US, Canada)
• Europe (UK, Germany, Spain, France, Italy)
• Asia (China, India, Japan, Pakistan)
• Latin America (Brazil, Argentina, Mexico)
• Middle East and North Africa (Israel, Egypt, Saudi Arabia)

Research Coverage:

• An outline of the systematic research approach used for the study of insulin pump market, featuring an overview of the key assumptions, research methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An in-depth assessment of the key factors including economic, strategic, technological, and institutional drivers impacting the growth of the insulin pump industry. Further, this section highlights key factors affecting market dynamics and the strong quality control framework implemented to guarantee transparency and credibility in the insights provided to the clients.
• An executive summary of the insights captured during our research, offering an overview of the current insulin pump market. Additionally, this section presents information on the most relevant trends, challenges and opportunities that are shaping the industry's development.
• A brief overview of diabetes, along with information on insulin pumps and their types. The module covers the advantages and drawbacks associated with the use of insulin pumps. In addition, it discusses the anticipated future trends in this domain.
• A detailed assessment of the current market landscape of insulin pumps, along with information on several relevant parameters, such as stage of development (under development and commercialized), launch year, type of pump (tethered pumps and patch pumps), degree of automation (manual pumps and automated / smart pumps), type of diabetes targeted (type 1 diabetes and type 2 diabetes), type of doses administered (basal and bolus), reservoir capacity and type of battery (replaceable batteries and rechargeable batteries). In addition, this section covers a detailed list of players engaged in manufacturing insulin pumps, along with analysis based on various parameters, such as year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe and Asia-Pacific), type of company (public and private), and the most active players in this domain (in terms of number of insulin pumps manufactured).

• Elaborate profiles of prominent players manufacturing insulin pumps, based across different geographies, including North America, Europe and Asia-Pacific. Each profile features a brief overview of the company (including information on its year of establishment, location of headquarters, number of employees, leadership team, business segments and contact details), financial information (if available), insulin pump portfolio, recent developments and an informed future outlook.
• An in-depth analysis of patents that have been filed / granted in insulin pump domain, since 2021, based on several relevant parameters, such as the type of patent (granted patents, patent applications and others), patent publication year, patent application year, patent jurisdiction, Cooperative Patent Classification (CPC) symbols, type of applicant, and most active industry and non-industry players (in terms of number of patents filed / granted). In addition, it includes patent benchmarking and an insightful patent valuation analysis, highlighting the leading players (in terms of number of citations).

• Detailed analysis of the factors that are likely to impact the growth of the insulin pump market. Further, the report also provides insights on the key drivers, potential restraints, emerging opportunities, and existing challenges in the insulin pump industry.
• A detailed estimate of the current market size, opportunity and the future growth potential of the insulin pump industry over the next decade. Based on multiple parameters, such as likely adoption trends and through primary validations, we have provided an informed estimate on the market evolution, during the forecast period till 2035.

• Detailed projections of the current and future opportunity within the insulin pump market based on different types of pumps, such as tethered pumps and patch pumps.
• Detailed projections of the current and future opportunity within the insulin pump industry based on the degree of automation, such as manual pumps and automated / smart pumps.
• Detailed projections of the current and future opportunity within the insulin pump market, based on various types of batteries, such as replaceable batteries and rechargeable batteries.
• Detailed projections of the current and future opportunity within the insulin pump market across different types of diabetes, such as type 1 diabetes and type 2 diabetes.
• Detailed projections of the current and future opportunity within the insulin pump industry based on various distribution channels, such as retail pharmacies, hospital pharmacies, online pharmacies and other pharmacies.
• Detailed predictions of the current and future opportunity within the insulin pump market across key geographical regions, such as North America, Europe, Asia, Latin America, and Middle East and North Africa.

Key Benefits of Buying this Report

• The report offers valuable insights into revenue estimation for both the overall market and its sub-segments, in order to empower market leaders and newcomers with critical information requisite for establishing their footprint in the industry.
• The report can be utilized by stakeholders to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a comprehensive view on the insulin pump market, covering essential information on significant market drivers, barriers, opportunities, and challenges.

Example Companies Profiled

• Beta Bionics
• CeQur
• EOFlow
• Insulet Corporation
• LA Roche
• MannKind
• Medtronic
• Medtrum Technologies
• MicroPort
• Microtech Medical
• SOOIL Development
• Tandem Diabetes Care
• Terumo
• ViCentra
• Ypsomed

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Market Share Insights
• 1.3. Key Market Insights
• 1.4. Report Coverage
• 1.5. Key Questions Answered
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
  • 2.2.1. Market Landscape and Market Trends
  • 2.2.2. Market Forecast and Opportunity Analysis
  • 2.2.3. Comparative Analysis
• 2.3. Database Building
  • 2.3.1. Data Collection
  • 2.3.2. Data Validation
  • 2.3.3. Data Analysis
• 2.4. Project Methodology
  • 2.4.1. Secondary Research
    • 2.4.1.1. Annual Reports
    • 2.4.1.2. Academic Research Papers
    • 2.4.1.3. Company Websites
    • 2.4.1.4. Investor Presentations
    • 2.4.1.5. Regulatory Filings
    • 2.4.1.6. White Papers
    • 2.4.1.7. Industry Publications
    • 2.4.1.8. Conferences and Seminars
    • 2.4.1.9. Government Portals
    • 2.4.1.10. Media and Press Releases
    • 2.4.1.11. Newsletters
    • 2.4.1.12. Industry Databases
    • 2.4.1.13. Roots Proprietary Databases
    • 2.4.1.14. Paid Databases and Sources
    • 2.4.1.15. Social Media Portals
    • 2.4.1.16. Other Secondary Sources
  • 2.4.2. Primary Research
    • 2.4.2.1. Types of Primary Research
      • 2.4.2.1.1. Qualitative Research
      • 2.4.2.1.2. Quantitative Research
      • 2.4.2.1.3. Hybrid Approach
    • 2.4.2.2. Advantages of Primary Research
    • 2.4.2.3. Techniques for Primary Research
      • 2.4.2.3.1. Interviews
      • 2.4.2.3.2. Surveys
      • 2.4.2.3.3. Focus Groups
      • 2.4.2.3.4. Observational Research
      • 2.4.2.3.5. Social Media Interactions
    • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
      • 2.4.2.4.1. Company Executives (CXOs)
      • 2.4.2.4.2. Board of Directors
      • 2.4.2.4.3. Company Presidents and Vice Presidents
      • 2.4.2.4.4. Research and Development Heads
      • 2.4.2.4.5. Technical Experts
      • 2.4.2.4.6. Subject Matter Experts
      • 2.4.2.4.7. Scientists
      • 2.4.2.4.8. Doctors and Other Healthcare Providers
    • 2.4.2.5. Ethics and Integrity
      • 2.4.2.5.1. Research Ethics
      • 2.4.2.5.2. Data Integrity
  • 2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS

• 3.1. Chapter Overview
• 3.2. Forecast Methodology
  • 3.2.1. Top-down Approach
  • 3.2.2. Bottom-up Approach
  • 3.2.3. Hybrid Approach
• 3.3. Market Assessment Framework
  • 3.3.1. Total Addressable Market (TAM)
  • 3.3.2. Serviceable Addressable Market (SAM)
  • 3.3.3. Serviceable Obtainable Market (SOM)
  • 3.3.4. Currently Acquired Market (CAM)
• 3.4. Forecasting Tools and Techniques
  • 3.4.1. Qualitative Forecasting
  • 3.4.2. Correlation
  • 3.4.3. Regression
  • 3.4.4. Extrapolation
  • 3.4.5. Convergence
  • 3.4.6. Sensitivity Analysis
  • 3.4.7. Scenario Planning
  • 3.4.8. Data Visualization
  • 3.4.9. Time Series Analysis
  • 3.4.10. Forecast Error Analysis
• 3.5. Key Considerations
  • 3.5.1. Demographics
  • 3.5.2. Government Regulations
  • 3.5.3. Reimbursement Scenarios
  • 3.5.4. Market Access
  • 3.5.5. Supply Chain
  • 3.5.6. Industry Consolidation
  • 3.5.7. Pandemic / Unforeseen Disruptions Impact
• 3.6. Key Market Segmentation
• 3.7. Robust Quality Control
• 3.8. Limitations

4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 4.1. Chapter Overview
• 4.2. Market Dynamics
  • 4.2.1. Time Period
    • 4.2.1.1. Historical Trends
    • 4.2.1.2. Current and Forecasted Estimates
  • 4.2.2. Currency Coverage
    • 4.2.2.1. Overview of Major Currencies Affecting the Market
    • 4.2.2.2. Impact of Currency Fluctuations on the Industry
  • 4.2.3. Foreign Exchange Impact
    • 4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 4.2.4. Recession
    • 4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 4.2.5. Inflation
    • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 4.2.5.2. Potential Impact of Inflation on the Market Evolution

5. EXECUTIVE SUMMARY

6. INTRODUCTION

• 6.1. Chapter Overview
• 6.2. Overview of Diabetes
  • 6.2.1. Classification of Diabetes
• 6.3. Insulin Pumps
  • 6.3.1. Types of Insulin Pumps
  • 6.3.2. Advantages of Insulin Pumps
  • 6.3.3. Limitations of Insulin Pumps
• 6.4. Future Perspectives

7. INSULIN PUMPS: MARKET LANDSCAPE

• 7.1. Chapter Overview
• 7.2. Insulin Pumps: Overall Market Landscape
  • 7.2.1. Analysis by Stage of Development
  • 7.2.2. Analysis by Launch Year
  • 7.2.3. Analysis by Type of Pump
  • 7.2.4. Analysis by Degree of Automation
  • 7.2.5. Analysis by Type of Diabetes Targeted
  • 7.2.6. Analysis by Type of Dose Administered
  • 7.2.7. Analysis by Reservoir Capacity
  • 7.2.8. Analysis by Type of Battery
• 7.3. Insulin Pumps: List of Manufacturer
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Location of Headquarters
  • 7.3.4. Analysis by Company Size and Location of Headquarters
  • 7.3.5. Analysis by Type of Company
  • 7.3.6. Most Active Players: Analysis by Number of Insulin Pumps Manufactured

8. COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN NORTH AMERICA

• 8.1. Chapter Overview
• 8.2. Beta Bionics
  • 8.2.1. Company Overview
  • 8.2.2. Insulin Pumps Portfolio
  • 8.2.3. Recent Developments and Future Outlook
• 8.3. Insulet
  • 8.3.1. Company Overview
  • 8.3.2. Insulin Pumps Portfolio
  • 8.3.3. Recent Developments and Future Outlook
• 8.4. MannKind
  • 8.4.1. Company Overview
  • 8.4.2. Insulin Pumps Portfolio
  • 8.4.3. Recent Developments and Future Outlook
• 8.5. Medtronic
  • 8.5.1. Company Overview
  • 8.5.2. Insulin Pumps Portfolio
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. Tandem Diabetes Care
  • 8.6.1. Company Overview
  • 8.6.2. Insulin Pumps Portfolio
  • 8.6.3. Recent Developments and Future Outlook

9. COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN EUROPE

• 9.1. Chapter Overview
• 9.2. CeQur
  • 9.2.1. Company Overview
  • 9.2.2. Insulin Pumps Portfolio
  • 9.2.3. Recent Developments and Future Outlook
• 9.3. Roche
  • 9.3.1. Company Overview
  • 9.3.2. Financial Information
  • 9.3.3. Insulin Pumps Portfolio
  • 9.3.4. Recent Developments and Future Outlook
• 9.4. ViCentra
  • 9.4.1. Company Overview
  • 9.4.2. Insulin Pumps Portfolio
  • 9.4.3. Recent Developments and Future Outlook
• 9.5. Ypsomed
  • 9.5.1. Company Overview
  • 9.5.2. Financial Information
  • 9.5.3. Insulin Pumps Portfolio
  • 9.5.4. Recent Developments and Future Outlook

10. COMPANY PROFILES: INSULIN PUMP MANUFACTURERS BASED IN ASIA-PACIFIC

• 10.1. Chapter Overview
• 10.2. EOFlow
  • 10.2.1. Company Overview
  • 10.2.2. Financial Information
  • 10.2.3. Insulin Pumps Portfolio
  • 10.2.4. Recent Developments and Future Outlook
• 10.3. Medtrum Technologies
  • 10.3.1. Company Overview
  • 10.3.2. Insulin Pumps Portfolio
  • 10.3.3. Recent Developments and Future Outlook
• 10.4. MicroPort
  • 10.4.1. Company Overview
  • 10.4.2. Financial Information
  • 10.4.3. Insulin Pumps Portfolio
  • 10.4.4. Recent Developments and Future Outlook
• 10.5. Microtech Medical
  • 10.5.1. Company Overview
  • 10.5.2. Financial Information
  • 10.5.3. Insulin Pumps Portfolio
  • 10.5.4. Recent Developments and Future Outlook
• 10.6. SOOIL Development
  • 10.6.1. Company Overview
  • 10.6.2. Financial Information
  • 10.6.3. Insulin Pumps Portfolio
  • 10.6.4. Recent Developments and Future Outlook
• 10.7. Terumo
  • 10.7.1. Company Overview
  • 10.7.2. Financial Information
  • 10.7.3. Insulin Pumps Portfolio
  • 10.7.4. Recent Developments and Future Outlook

11. PATENT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Insulin Pumps: Patent Analysis
  • 11.3.1. Analysis by Patent Publication Year
  • 11.3.2. Analysis by Patent Application Year
  • 11.3.3. Analysis by Type of Patent and Publication Year
  • 11.3.4. Analysis by Patent Jurisdiction
  • 11.3.5. Analysis by CPC Symbols
  • 11.3.6. Analysis by Type of Applicant
  • 11.3.7. Leading Industry Players: Analysis by Number of Patents
  • 11.3.8. Leading Non-industry Players: Analysis by Number of Patents
  • 11.3.9. Leading Patent Assignees: Analysis by Number of Patents
• 11.4. Patent Benchmarking Analysis
  • 11.4.1. Analysis of Patent Characteristics (CPC codes) by Leading Industry Players
  • 11.4.2. Analysis of Leading Industry Players by Patent Characteristics (CPC codes)
• 11.5. Patent Valuation
• 11.6. Leading Patents by Number of Citations

12. MARKET IMPACT ANALYSIS

• 12.1. Chapter Overview
• 12.2. Market Drivers
• 12.3. Market Restraints
• 12.4. Market Opportunities
• 12.5. Market Challenges
• 12.6. Conclusion

13. GLOBAL INSULIN PUMPS MARKET

• 13.1. Chapter Overview
• 13.2. Key Assumptions and Methodology
• 13.3. Global Insulin Pumps Market, till 2035
  • 13.3.1. Scenario Analysis
    • 13.3.1.1. Conservative Scenario
    • 13.3.1.2. Optimistic Scenario
• 13.4. Key Market Segmentations
• 13.5. Leading Industry Players

14. INSULIN PUMPS MARKET, BY TYPE OF PUMP

• 14.1. Chapter Overview
• 14.2. Key Assumptions and Methodology
• 14.3. Insulin Pumps Market: Distribution by Type of Pump, 2017, Current Year and 2035
  • 14.3.1. Insulin Pumps Market for Tethered Pumps, till 2035
  • 14.3.2. Insulin Pumps Market for Patch Pumps, till 2035
• 14.4. Data Triangulation and Validation

15. INSULIN PUMPS MARKET, BY DEGREE OF AUTOMATION

• 15.1. Chapter Overview
• 15.2. Key Assumptions and Methodology
• 15.3. Insulin Pumps Market: Distribution by Degree of Automation, 2017, Current Year and 2035
  • 15.3.1. Insulin Pumps Market for Manual Pumps, till 2035
  • 15.3.2. Insulin Pumps Market for Automated / Smart Pumps, till 2035
• 15.4. Data Triangulation and Validation

16. INSULIN PUMPS MARKET, BY TYPE OF BATTERY

• 16.1. Chapter Overview
• 16.2. Key Assumptions and Methodology
• 16.3. Insulin Pumps Market: Distribution by Type of Battery, 2017, Current Year and 2035
  • 16.3.1. Insulin Pumps Market for Replaceable Batteries, till 2035
  • 16.3.2. Insulin Pumps Market for Rechargeable Batteries, till 2035
• 16.4. Data Triangulation and Validation

17. INSULIN PUMPS MARKET, BY TYPE OF DIABETES TARGETED

• 17.1. Chapter Overview
• 17.2. Key Assumptions and Methodology
• 17.3. Insulin Pumps Market: Distribution by Type of Diabetes Targeted, 2017, Current Year and 2035
  • 17.3.1. Insulin Pumps Market for Type 1 Diabetes, till 2035
    • 17.3.1.1. Insulin Pumps Market for Type 1 Diabetes in North America, till 2035
      • 17.3.1.1.1. Insulin Pumps Market for Type 1 Diabetes in the US, till 2035
      • 17.3.1.1.2. Insulin Pumps Market for Type 1 Diabetes in Canada, till 2035
    • 17.3.1.2. Insulin Pumps Market for Type 1 Diabetes in Europe, till 2035
      • 17.3.1.2.1. Insulin Pumps Market for Type 1 Diabetes in the UK, till 2035
      • 17.3.1.2.2. Insulin Pumps Market for Type 1 Diabetes in Germany, till 2035
      • 17.3.1.2.3. Insulin Pumps Market for Type 1 Diabetes in Spain, till 2035
      • 17.3.1.2.4. Insulin Pumps Market for Type 1 Diabetes in Italy, till 2035
      • 17.3.1.2.5. Insulin Pumps Market for Type 1 Diabetes in France, till 2035
    • 17.3.1.3. Insulin Pumps Market for Type 1 Diabetes in Asia, till 2035
      • 17.3.1.3.1. Insulin Pumps Market for Type 1 Diabetes in China, till 2035
      • 17.3.1.3.2. Insulin Pumps Market for Type 1 Diabetes in Japan, till 2035
      • 17.3.1.3.3. Insulin Pumps Market for Type 1 Diabetes in India, till 2035
      • 17.3.1.3.4. Insulin Pumps Market for Type 1 Diabetes in Pakistan, till 2035
    • 17.3.1.4. Insulin Pumps Market for Type 1 Diabetes in Middle East and North Africa, till 2035
      • 17.3.1.4.1. Insulin Pumps Market for Type 1 Diabetes in Israel, till 2035
      • 17.3.1.4.2. Insulin Pumps Market for Type 1 Diabetes in Egypt, till 2035
      • 17.3.1.4.3. Insulin Pumps Market for Type 1 Diabetes in Saudi Arabia, till 2035
    • 17.3.1.5. Insulin Pumps Market for Type 1 Diabetes in Latin America, till 2035
      • 17.3.1.5.1. Insulin Pumps Market for Type 1 Diabetes in Brazil, till 2035
      • 17.3.1.5.2. Insulin Pumps Market for Type 1 Diabetes in Argentina, till 2035
      • 17.3.1.5.3. Insulin Pumps Market for Type 1 Diabetes in Mexico, till 2035
  • 17.3.2. Insulin Pumps Market for Type 2 Diabetes, till 2035
    • 17.3.2.1. Insulin Pumps Market for Type 2 Diabetes in North America, till 2035
      • 17.3.2.1.1. Insulin Pumps Market for Type 2 Diabetes in the US, till 2035
      • 17.3.2.1.2. Insulin Pumps Market for Type 2 Diabetes in Canada, till 2035
    • 17.3.2.2. Insulin Pumps Market for Type 2 Diabetes in Europe, till 2035
      • 17.3.2.2.1. Insulin Pumps Market for Type 2 Diabetes in the UK, till 2035
      • 17.3.2.2.2. Insulin Pumps Market for Type 2 Diabetes in Germany, till 2035
      • 17.3.2.2.3. Insulin Pumps Market for Type 2 Diabetes in Spain, till 2035
      • 17.3.2.2.4. Insulin Pumps Market for Type 2 Diabetes in Italy, till 2035
      • 17.3.2.2.5. Insulin Pumps Market for Type 2 Diabetes in France, till 2035
    • 17.3.2.3. Insulin Pumps Market for Type 2 Diabetes in Asia, till 2035
      • 17.3.2.3.1. Insulin Pumps Market for Type 2 Diabetes in China, till 2035
      • 17.3.2.3.2. Insulin Pumps Market for Type 2 Diabetes in Japan, till 2035
      • 17.3.2.3.3. Insulin Pumps Market for Type 2 Diabetes in India, till 2035
      • 17.3.2.3.4. Insulin Pumps Market for Type 2 Diabetes in Pakistan, till 2035
    • 17.3.2.4. Insulin Pumps Market for Type 2 Diabetes in Middle East and North Africa, till 2035
      • 17.3.2.4.1. Insulin Pumps Market for Type 2 Diabetes in Israel, till 2035
      • 17.3.2.4.2. Insulin Pumps Market for Type 2 Diabetes in Egypt, till 2035
      • 17.3.2.4.3. Insulin Pumps Market for Type 2 Diabetes in Saudi Arabia, till 2035
    • 17.3.2.5. Insulin Pumps Market for Type 2 Diabetes in Latin America, till 2035
      • 17.3.2.5.1. Insulin Pumps Market for Type 2 Diabetes in Brazil, till 2035
      • 17.3.2.5.2. Insulin Pumps Market for Type 2 Diabetes in Argentina, till
      • 17.3.2.5.3. Insulin Pumps Market for Type 2 Diabetes in Mexico, till 2035
• 17.4. Data Triangulation and Validation

18. INSULIN PUMPS MARKET, BY DISTRIBUTION CHANNEL

• 18.1. Chapter Overview
• 18.2. Key Assumptions and Methodology
• 18.3. Insulin Pumps Market: Distribution by Distribution Channel, 2017, Current Year and 2035
  • 18.3.1. Insulin Pumps Market for Retail Pharmacies, till 2035
  • 18.3.2. Insulin Pumps Market for Hospital Pharmacies, till 2035
  • 18.3.3. Insulin Pumps Market for Online Pharmacies, till 2035
  • 18.3.4. Insulin Pumps Market for Other Pharmacies, till 2035
• 18.4. Data Triangulation and Validation

19. INSULIN PUMPS MARKET, BY GEOGRAPHY

• 19.1. Chapter Overview
• 19.2. Assumptions and Methodology
• 19.3. Insulin Pumps Market: Distribution by Geography, 2017, Current Year and 2035
  • 19.3.1. Insulin Pumps Market in North America, till 2035
    • 19.3.1.1. Insulin Pumps Market in the US, till 2035
    • 19.3.1.2. Insulin Pumps Market in Canada, till 2035
  • 19.3.2. Insulin Pumps Market in Europe, till 2035
    • 19.3.2.1. Insulin Pumps Market in the UK, till 2035
    • 19.3.2.2. Insulin Pumps Market in Germany, till 2035
    • 19.3.2.3. Insulin Pumps Market in Spain, till 2035
    • 19.3.2.4. Insulin Pumps Market in Italy, till 2035
    • 19.3.2.5. Insulin Pumps Market in France, till 2035
  • 19.3.3. Insulin Pumps Market in Asia, till 2035
    • 19.3.3.1. Insulin Pumps Market in China, till 2035
    • 19.3.3.2. Insulin Pumps Market in Japan, till 2035
    • 19.3.3.3. Insulin Pumps Market in India, till 2035
    • 19.3.3.4. Insulin Pumps Market in Pakistan, till 2035
  • 19.3.4. Insulin Pumps Market in Middle East and North Africa, till 2035
    • 19.3.4.1. Insulin Pumps Market in Israel, till 2035
    • 19.3.4.2. Insulin Pumps Market in Egypt, till 2035
    • 19.3.4.3. Insulin Pumps Market in Saudi Arabia, till 2035
  • 19.3.5. Insulin Pumps Market in Latin America, till 2035
    • 19.3.5.1. Insulin Pumps Market in Brazil, till 2035
    • 19.3.5.2. Insulin Pumps Market in Argentina, till 2035
    • 19.3.5.3. Insulin Pumps Market in Mexico, till 2035
• 19.4. Insulin Pumps Market, By Geography: Market Dynamics Assessment
  • 19.4.1. Penetration Growth (P-G) Matrix
  • 19.4.2. Market Movement Analysis
• 19.5. Data Triangulation and Validation

20. CONCLUDING REMARKS

21. EXECUTIVE INSIGHTS

22. APPENDIX I: TABULATED DATA

23. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

관련자료